Key Highlights
- No indirect holdings or derivative transactions were involved; all shares were disposed of from direct ownership.
- These 10 stocks could mint the next wave of millionaires › Evan Kearns, the chief legal officer at Cogent Biosciences (NASDAQ:COGT), reported an open-market sale of 65,000 shares for a transaction value of $2.52 million, according to a Dec.
- 30 SEC Form 4 filing.
- Transaction summary Metric Value Shares sold (direct) 65,000 Transaction value $2.5 million Post-transaction shares (direct) 109,398 Post-transaction value (direct ownership) $4.25 million Transaction value based on SEC Form 4 weighted average purchase price ($38.70); post-transaction value based on Dec.
- 26 market close price used in SEC calculations.
